Watch Scarlet and Paul LIVE every day on YouTube: http://bit.ly/3vTiACF.
Market news and in-depth company research.
Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu
- Stephen Flynn, Bloomberg Intelligence Senior Credit Analyst, discusses Warner Bros Discovery agreeing to reopen negotiations with Paramount Skydance Corp. after Paramount proposed raising its bid and sweetened other terms of its offer. Netflix Inc. has granted Warner Bros. seven days to discuss Paramount's proposal, with Warner Bros. still recommending shareholders vote in favor of its binding agreement to sell to Netflix.
- Mandeep Singh, Global Tech Research Head at Bloomberg Intelligence, discusses the latest on Anthropic. Anthropic PBC's talks to extend a contract with the Pentagon are being held up over additional protections the company wants to put on its Claude tool.
-Sam Fazeli, Bloomberg Intelligence, Director of Research for Global Industries and Senior Pharmaceuticals Analyst, discusses the latest in the biotech sector. According to Bloomberg Intelligence: Moderna and Merck's positive Phase 2 data from intismeran autogene (2030 consensus sales of $1.3 billion) in adjuvant melanoma has led to three Phase 3 trials, but the first, Moderna's key 2026 clinical catalyst in melanoma (data due 2H), faces headwinds.
-Jeffrey Langbaum, Bloomberg Intelligence Senior US REIT Analyst, discusses the latest in real estate. According to Bloomberg Intelligence: Contrary to widespread concerns about artificial intelligence eliminating jobs, the technology is emerging as a catalyst for office demand, reinforcing leasing momentum in New York City and San Francisco.
See omnystudio.com/listener for privacy information.
